Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Christopher S. Stauffer"'
Autor:
Elliot Marseille, Christopher S. Stauffer, Manish Agrawal, Paul Thambi, Kimberly Roddy, Michael Mithoefer, Stefano M. Bertozzi, James G. Kahn
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
ObjectiveTo compare group and individual psychedelic-assisted therapy in terms of clinician time, costs and patient access.MethodsUsing 2023 data from two group therapy trial sites, one using 3,4-Methylenedioxymethamphetamine (MDMA) to treat posttrau
Externí odkaz:
https://doaj.org/article/27b541510ba847218d035b5148283727
Autor:
Jonathan Brett, Elizabeth Knock, P. Todd Korthuis, Paul Liknaitzky, Kevin S. Murnane, Christopher R. Nicholas, James C. Patterson, Christopher S. Stauffer
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
Methamphetamine use disorder is a chronic relapsing condition associated with substantial mental, physical, and social harms and increasing rates of mortality. Contingency management and psychotherapy interventions are the mainstays of treatment but
Externí odkaz:
https://doaj.org/article/32d58082fc734733bcbddda1eb05009b
Autor:
Katherine R. Thorson, Scott M. McKernan, Tessa V. West, Joshua D. Woolley, Wendy Berry Mendes, Christopher S. Stauffer
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Patients and psychotherapists often exhibit behavioral, psychological, and physiological similarity. Here, we test whether oxytocin—a neuropeptide that can enhance expressivity and social perception—influences time-lagged “linkage” o
Externí odkaz:
https://doaj.org/article/f2543d326c0448cbbc847c47e9ed4c81
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
IntroductionTransgender and gender diverse (TGD) people experience stigma, discrimination, trauma, and post-traumatic stress disorder (PTSD) at higher rates compared to the general population; however, TGD people have been underrepresented in PTSD re
Externí odkaz:
https://doaj.org/article/68b4315496734f218371d8f22c0adb42
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2022)
The increasing prevalence of illicit stimulant use among those in opioid treatment programs poses a significant risk to public health, stimulant users have the lowest rate of retention and poorest outcomes among those in addiction treatment, and curr
Externí odkaz:
https://doaj.org/article/1e2a20c9289f4cb59915058218c7298b
Autor:
Christopher S. Stauffer, Jenna M. Moschetto, Scott M. McKernan, Elaine Hsiang, Brian Borsari, Joshua D. Woolley
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background The prevalence of methamphetamine use disorder (MUD) in the United States has risen dramatically in the past four decades and is concentrated in populations such as men who have sex with men (MSM). Despite the public health conseq
Externí odkaz:
https://doaj.org/article/c68d69cb3e8246b384dc5312bf201913
Publikováno v:
Addictive Behaviors Reports, Vol 10, Iss , Pp - (2019)
Introduction: Social isolation and alcohol and substance use disorders (ASUD) have been identified as global health risks. Social support is protective against developing ASUD and is associated with beneficial addiction treatment outcomes. Socially s
Externí odkaz:
https://doaj.org/article/add31b60fe014c57a19e0d6bb84a93b7
Publikováno v:
Psychopharmacology (Berl)
RATIONALE & OBJECTIVES: ±3,4-Methylenedioxymethamphetamine (MDMA) and psilocybin are currently moving through the US Food and Drug Administration’s phased drug development process for psychiatric treatment indications: posttraumatic stress disorde
Autor:
Christopher S. Stauffer, Joshua D. Woolley, Scott McKernan, Katherine R. Thorson, Wendy Berry Mendes, Tessa V. West
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports
Scientific Reports
Patients and psychotherapists often exhibit behavioral, psychological, and physiological similarity. Here, we test whether oxytocin—a neuropeptide that can enhance expressivity and social perception—influences time-lagged “linkage” of autonom
Publikováno v:
ACS Pharmacol Transl Sci
[Image: see text] Attachment insecurity is determined early in life, is a risk factor for psychopathology, and can be measured on two separate continuous dimensions: attachment anxiety and attachment avoidance. Therapeutic changes toward more secure